These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 10617149

  • 21. Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization.
    Mundell SJ, Luty JS, Willets J, Benovic JL, Kelly E.
    Br J Pharmacol; 1998 Sep; 125(2):347-56. PubMed ID: 9786508
    [Abstract] [Full Text] [Related]

  • 22. Trafficking of adenosine A2A and dopamine D2 receptors.
    Torvinen M, Torri C, Tombesi A, Marcellino D, Watson S, Lluis C, Franco R, Fuxe K, Agnati LF.
    J Mol Neurosci; 2005 Sep; 25(2):191-200. PubMed ID: 15784967
    [Abstract] [Full Text] [Related]

  • 23. Adenosine modulates hypoxia-induced responses in rat PC12 cells via the A2A receptor.
    Kobayashi S, Conforti L, Pun RY, Millhorn DE.
    J Physiol; 1998 Apr 01; 508 ( Pt 1)(Pt 1):95-107. PubMed ID: 9490823
    [Abstract] [Full Text] [Related]

  • 24. Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum.
    Díaz-Cabiale Z, Hurd Y, Guidolin D, Finnman UB, Zoli M, Agnati LF, Vanderhaeghen JJ, Fuxe K, Ferré S.
    Neuroreport; 2001 Jul 03; 12(9):1831-4. PubMed ID: 11435907
    [Abstract] [Full Text] [Related]

  • 25. Effects of adenosine A(2A) receptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain.
    Hillefors M, Hedlund PB, von Euler G.
    Biochem Pharmacol; 1999 Dec 15; 58(12):1961-4. PubMed ID: 10591151
    [Abstract] [Full Text] [Related]

  • 26. Adenosine-dopamine receptor interactions in the isolated rat nodose ganglion but not in membranes of dorsal vagal complex.
    Lawrence AJ, Krstew E, Jarrott B.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb 15; 355(2):303-8. PubMed ID: 9050027
    [Abstract] [Full Text] [Related]

  • 27. Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680.
    Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Goldberg SR, Ferré S.
    Eur J Pharmacol; 2004 Jan 26; 484(2-3):269-75. PubMed ID: 14744613
    [Abstract] [Full Text] [Related]

  • 28. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
    Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, Wilder RL, Elenkov IJ.
    J Immunol; 2000 Jan 01; 164(1):436-42. PubMed ID: 10605040
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors.
    Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, Franco R, Ferre S, Fuxe K.
    J Biol Chem; 2002 May 17; 277(20):18091-7. PubMed ID: 11872740
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns.
    López-Cruz L, San Miguel N, Carratalá-Ros C, Monferrer L, Salamone JD, Correa M.
    Neuropharmacology; 2018 Aug 17; 138():349-359. PubMed ID: 29408363
    [Abstract] [Full Text] [Related]

  • 34. A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system.
    Latini S, Pazzagli M, Pepeu G, Pedata F.
    Gen Pharmacol; 1996 Sep 17; 27(6):925-33. PubMed ID: 8909972
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Endogenous adenosine reduces glutamatergic output from rods through activation of A2-like adenosine receptors.
    Stella SL, Bryson EJ, Cadetti L, Thoreson WB.
    J Neurophysiol; 2003 Jul 17; 90(1):165-74. PubMed ID: 12843308
    [Abstract] [Full Text] [Related]

  • 37. Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart.
    Norton GR, Woodiwiss AJ, McGinn RJ, Lorbar M, Chung ES, Honeyman TW, Fenton RA, Dobson JG, Meyer TE.
    Am J Physiol; 1999 Feb 17; 276(2):H341-9. PubMed ID: 9950832
    [Abstract] [Full Text] [Related]

  • 38. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.
    Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G.
    Proc Natl Acad Sci U S A; 2000 Feb 15; 97(4):1856-60. PubMed ID: 10677546
    [Abstract] [Full Text] [Related]

  • 39. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP, Cattabeni F.
    Ann N Y Acad Sci; 1999 Feb 15; 890():79-92. PubMed ID: 10668415
    [Abstract] [Full Text] [Related]

  • 40. Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.
    Liang BT, Haltiwanger B.
    Circ Res; 1995 Feb 15; 76(2):242-51. PubMed ID: 7834835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.